187 related articles for article (PubMed ID: 9101355)
41. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
Gong J; Xu J; Zhou K; Shen K
Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
[TBL] [Abstract][Full Text] [Related]
42. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction.
Ni Y; Petré C; Lukito G; Marchal G; Grant D; Gray TJ; Baert AL
Acad Radiol; 1995 Apr; 2(4):300-5. PubMed ID: 9419566
[TBL] [Abstract][Full Text] [Related]
43. Regional distribution of manganese found in the brain after injection of a single dose of manganese-based contrast agents.
Gallez B; Baudelet C; Geurts M
Magn Reson Imaging; 1998 Dec; 16(10):1211-5. PubMed ID: 9858278
[TBL] [Abstract][Full Text] [Related]
44. An apparent unidirectional influx constant for manganese as a measure of myocardial calcium channel activity.
Skjold A; Kristoffersen A; Vangberg TR; Haraldseth O; Jynge P; Larsson HB
J Magn Reson Imaging; 2006 Nov; 24(5):1047-55. PubMed ID: 17024667
[TBL] [Abstract][Full Text] [Related]
45. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part I: comparison with pathologic examination.
Kim TH; Yang DH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Gong GY; Lim TH
Invest Radiol; 2005 Jan; 40(1):49-55. PubMed ID: 15597020
[TBL] [Abstract][Full Text] [Related]
46. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium.
Karlsson JO; Brurok H; Eriksen M; Towart R; Toft KG; Moen O; Engebretsen B; Jynge P; Refsum H
Acta Radiol; 2001 Nov; 42(6):540-7. PubMed ID: 11736698
[TBL] [Abstract][Full Text] [Related]
47. Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
Karlsson JE; El-Saadi W; Ali M; Puskar W; Skogvard P; Engvall JE; Andersson RG; Maret E; Jynge P
Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):39-45. PubMed ID: 27533964
[TBL] [Abstract][Full Text] [Related]
48. Manganese and the heart: acute cardiodepression and myocardial accumulation of manganese.
Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P
Acta Physiol Scand; 1997 Jan; 159(1):33-40. PubMed ID: 9124068
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
Blume J; Palmié S; Aue B; Spielmann RP; Sievers E; Lodemann KP; Heller M
Acad Radiol; 1994 Nov; 1(3):253-60. PubMed ID: 9419495
[TBL] [Abstract][Full Text] [Related]
50. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
Yang DH; Kim TH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Lim TH
Invest Radiol; 2005 Jan; 40(1):56-61. PubMed ID: 15597021
[TBL] [Abstract][Full Text] [Related]
51. Mn-DPDP enhanced MRI in experimental bile duct obstruction.
Marchal G; Ni Y; Zhang X; Yu J; Lodemann KP; Baert AL
J Comput Assist Tomogr; 1993; 17(2):290-6. PubMed ID: 8454757
[TBL] [Abstract][Full Text] [Related]
52. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography.
Toft KG; Friisk GA; Skotland T
J Pharm Biomed Anal; 1997 Apr; 15(7):973-81. PubMed ID: 9160264
[TBL] [Abstract][Full Text] [Related]
53. Developmental toxicity study of mangafodipir trisodium injection (MnDPDP) in New Zealand white rabbits.
Blazak WF; Brown GL; Gray TJ; Treinen KA; Denny KH
Fundam Appl Toxicol; 1996 Sep; 33(1):11-5. PubMed ID: 8812204
[TBL] [Abstract][Full Text] [Related]
54. Detection of acute myocardial ischemia using first-pass dynamics of MnDPDP on inversion recovery echoplanar imaging.
Wyttenbach R; Saeed M; Wendland MF; Geschwind JF; Bremerich J; Arheden H; Higgins CB
J Magn Reson Imaging; 1999 Feb; 9(2):209-14. PubMed ID: 10077015
[TBL] [Abstract][Full Text] [Related]
55. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
[TBL] [Abstract][Full Text] [Related]
56. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
57. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.
Wang C; Gordon PB; Hustvedt SO; Grant D; Sterud AT; Martinsen I; Ahlström H; Hemmingsson A
Acta Radiol; 1997 Jul; 38(4 Pt 2):665-76. PubMed ID: 9245962
[TBL] [Abstract][Full Text] [Related]
58. Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging.
Ahlström H; Gehl HB
Acta Radiol; 1997 Jul; 38(4 Pt 2):660-4. PubMed ID: 9245961
[TBL] [Abstract][Full Text] [Related]
59. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
[TBL] [Abstract][Full Text] [Related]
60. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
